Napoleon Perdis
This article was originally published in The Rose Sheet
Executive Summary
Australian beauty firm will enter the U.S. via electronic retailer HSN, the company announces. Beginning in August, Napoleon Perdis will reach 89 mil. households in the U.S. with demonstrations of the makeup artist's techniques and showcasing of the makeup collections. "Interactive retail is where the world is at," brand founder and CEO Napoleon Perdis says in a statement. "I am excited to bring out the celebrity in the viewer and take red carpet and celebrity to reality through makeup tips and techniques that are simple and effective." The brand launched in the U.S. in 2005 and is currently sold at four Napoleon Perdis concept stores and Saks Fifth Avenue, among other doors...
You may also be interested in...
Marketing In Brief
Hollywood Lips: New Hollywood Lips Plumping Balm mixes "science with seduction and superstars," according to founder and creator Bret Boreman. Boreman, an L.A.-based makeup artist, launched the line in April at Hollywood boutiques such as Kitson. The line comprises three Plumping Balms - in coconut, tangerine and passion fruit - that rely on shea butter and safflower oil, among other ingredients, to "plump and perfect" lips. The collection also features three lip treatments including Sweet Sugar Scrub, an orange-flavored lip exfoliant, and two moisturizers - Hydrating Night Balm, and Soothing Day Relief - to prep, heal and repair lips prior to plumping. The items are available for individual sale - the balms for $9.95, the scrub for $7 and the moisturizers for $8 - at select boutiques and are available in two- and three-item sets online at 1www.hollywoodlipsonline.com...
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.